

Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.465, 2004-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


The Increasingly Complex Fourth Hurdle for Pharmaceuticals
By Cohen Joshua Stolk Elly Niezen Maartje
PharmacoEconomics, Vol. 25, Iss. 9, 2007-01 ,pp. :


The hurdle of antiandrogen drug resistance: drug design strategies
Expert Opinion on Drug Discovery, Vol. 8, Iss. 12, 2013-12 ,pp. :


Biofilms: An Extra Hurdle for Effective Antimicrobial Therapy
Current Pharmaceutical Design, Vol. 16, Iss. 20, 2010-07 ,pp. :

